000			02990nam a22004215i 4500
999			_c368034 _d368034 _x1
001			368034
003			ES-MaUEC
005			20230102121700.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			220202s2022 sz | s |||| 0|eng d
020			_a9783030906108
024	7		_a10.1007/978-3-030-90610-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aQR181 _b2022 EB
245	1	0	_aChikungunya Virus _cedited by Mark Heise.
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XI, 139 páginas) _b10 ilustraciones, 7 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
490	0		_aCurrent Topics in Microbiology and Immunology _x2196-9965 _v435
505	0		_aPreface -- Molecular Virology of Chikungunya Virus -- Understanding molecular pathogenesis with chikungunya virus research tools -- Chronic Chikungunya Virus Disease -- Chikungunya Virus Vaccines: Platforms, Progress, and Challenges -- Small Molecule Inhibitors Targeting Chikungunya Virus.
520			_aThis book provides readers with a collection of latest reviews written by Chikungunya virus (CHIKV) research leaders who cover topics related to CHIKV replication, advances in CHIKV research reagents and model system development, as well as the pathogenesis of chronic CHIKV disease. Moreover, the volume updates on recent progress in the development of therapeutics and vaccines for treatment and prevention of CHIKV-induced disease. Chikungunya virus (CHIKV) is a mosquito-borne pathogen that has re-emerged to become a significant global disease threat. Although CHIKV has historically been associated with localized outbreaks of debilitating polyarthralgia in Africa and Asia, factors such as increased global travel and viral adaptation to new mosquito vectors have led to the introduction and spread of CHIKV in new regions of the world, including the Americas. The re-emergence of CHIKV has stimulated significant interest both in understanding the biology of CHIKV and in the development of medical countermeasures against the virus.
988			_aSpringer_BiomedLife_2022
650		7	_2embne _aInmunología _9138330
700			_aHeise, Mark _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _9683424
776	0	8	_iPrinted edition: _z9783030906092
776	0	8	_iPrinted edition: _z9783030906115
776	0	8	_iPrinted edition: _z9783030906122
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-90610-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _ep _zSI